Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Biotecnologia

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 21/01/2025			Variaz. 5gg	Var. 1 gen.
0,6552 ^USD	+0,34%		+2,41%	-23,48%

21/01	Applied Therapeutics, Inc. nomina Reena Thomas Colacot come responsabile della qualità	CI
23/12	I principali ribassisti del mercato	MT

Altre lingue

Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT	01:01
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit	21/01
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality	21/01
Applied Therapeutics, Inc. Appoints Reena Thomas Colacot as Head of Quality	21/01
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT	21/01
Kessler Topaz Meltzer & Check, LLP Notifies Applied Therapeutics, Inc. Investors of Upcoming Deadline in Securities Fraud Class Action Lawsuit	20/01
Shareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	20/01
Contact Levi & Korsinsky by February 18, 2025 Deadline to Join Class Action Against Applied Therapeutics, Inc.(APLT)	17/01
APPLIED THERAPEUTICS Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024	16/01
Kessler Topaz Meltzer & Check, LLP Encourages Applied Therapeutics, Inc. (APLT) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit	16/01
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit	16/01
The Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline	16/01
Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit	14/01
APLT Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against Applied Therapeutics, Inc. (APLT)	14/01
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025	14/01
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT	14/01
APLT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) and Lead Plaintiff Deadline on February 18, 2025	14/01
Shareholders of Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT	13/01
Kessler Topaz Meltzer & Check, LLP Reminds APLT Investors of February 18, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm	12/01
Class Action Reminder for APLT Investors: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Securities Fraud Class Action Lawsuit	11/01
APLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit	11/01
Kessler Topaz Meltzer & Check, LLP Encourages Applied Therapeutics, Inc. Investors With Losses to Contact the Firm	10/01
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics Lawsuit - APLT	10/01
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - APLT	09/01
Lost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm	09/01

Iscriviti per accedere a più notizie

Registrazione 100% gratuita

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Applied Therapeutics, Inc.

Azioni

APLT

US03828A1016

Biotecnologia

Altre lingue

Filtri